Pennant Group, Inc. (PNTG) has 12 SEC Form 4 insider filings on record in the last 90 days. No insider purchases were filed — 3 sales totalling $272K. Most recent filing: Aug. 10, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Aug. 10, 2026 filed Aug. 6, 2026 | Steik Jason Paul Chief Clinical Officer | −$53,700 | 1,394 | −8% | Yes | |
|
|
||||||
| Aug. 10, 2026 filed Aug. 6, 2026 | Cheney Kirk Sterling EVP, GC and Corp Secy | −$53,661 | 1,393 | −7% | No | |
|
|
||||||
| Aug. 10, 2026 filed Aug. 6, 2026 | Guerisoli Brent Chief Executive Officer | −$165,067 | 4,285 | −4% | No | |
|
|
||||||
| July 17, 2026 filed July 15, 2026 | SMITH BARRY M Director | $0 | 1,900 | +2% | No | |
|
|
||||||
| July 17, 2026 filed July 15, 2026 | Christensen Christopher R. Director | $0 | 1,900 | +1% | No | |
|
|
||||||
Showing the 5 most recent of 12 filings in the last 90 days.
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free